Precigen(PGEN)

Search documents
Precigen(PGEN) - 2020 Q2 - Quarterly Report
2020-08-10 21:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR Table of Contents ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-36042 PRECIGEN, INC. (Exact name of registrant as specified in its charter) Virginia 26-0084895 (State or other jurisdi ...
Precigen(PGEN) - 2020 Q1 - Quarterly Report
2020-05-11 21:03
Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Table of Contents OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION PRECIGEN, INC. (Exact name of registrant as specified in its charter) Virginia 26-0084895 (I.R.S. Employer (State or other jurisdiction of incorporation or organization) 20374 Seneca ...
Precigen(PGEN) - 2020 Q1 - Earnings Call Presentation
2020-05-08 13:06
| --- | --- | --- | --- | --- | |----------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | Precigen, Inc. 1Q-2020 Business Update 6 May 2020 | | | | | | | | | | | | | | | | | Forward-looking Statements Some of the statements made in this presentation are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Precigen's curr ...
Precigen(PGEN) - 2020 Q1 - Earnings Call Transcript
2020-05-07 02:24
Precigen, Inc. (NASDAQ:PGEN) Q1 2020 Earnings Conference Call May 6, 2020 4:15 PM ET Company Participants Steven Harasym - VP, IR Helen Sabzevari - President & CEO Tom Samuelson - VP Conference Call Participants Jason Butler - JMP Securities Swayampakula Ramakanth - H.C. Wainwright & Co. Operator Good afternoon, and welcome to the Precigen First Quarter 2020 Business Update and Financial Results Conference Call. I will now turn the call over to Steve Harasym, Head of Investor Relations. Please go ahead. St ...
Precigen(PGEN) - 2019 Q4 - Earnings Call Transcript
2020-03-03 10:29
Precigen, Inc. (NASDAQ:PGEN) Q4 2019 Earnings Conference Call March 2, 2020 5:30 PM ET Company Participants Steve Harasym - Vice President of Investor Relations Helen Sabzevari - President and Chief Executive Officer Tom Samuelson - Vice President of Finance Conference Call Participants Jason Butler - JMP Securities Operator Good afternoon, and welcome to the Precigen Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note, that this event is being recorded. I wo ...
Precigen(PGEN) - 2019 Q4 - Earnings Call Presentation
2020-03-03 10:06
| --- | --- | --- | --- | |------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Precigen 4Q-2019 Business Update 2 March 2020 | | | | | | | | | | | | | | Forward-looking Statements Some of the statements made in this presentation are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Precigen's current expectations and projections about futur ...
Precigen(PGEN) - 2019 Q4 - Annual Report
2020-03-02 21:54
Table of Contents For the transition period from to . Commission File Number: 001-36042 PRECIGEN, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation o ...
Intrexon (XON) Presents At Biotech Showcase Investor Conference - Slideshow
2020-01-17 17:58
| --- | --- | |--------------------------------------------------------------------------------------|--------------| | | January 2020 | | TRIPLE-GENE Therapeutics Advanced Gene & Cell Therapies for Cardiovascular Disease | | | Thomas D Reed, PhD: Co-Founder | | | Biotech Showcase, January 15, 2020 | | Forward Looking Statements Safe Harbor Statement Some of the statements made in this presentation are forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the s ...
Intrexon Corporation (XON) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
2020-01-15 18:55
| --- | --- | --- | --- | --- | |-----------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | Precigen, Inc. | | | | | | | | | | | | Helen Sabzevari, PhD President & CEO | | | | | | 14 January 2020 38th Annual J.P. Morgan Healthcare Conference | | | | | | | | | | | | | | | | | Forward-looking statements Precigen, Inc. is a subsidiary of Intrexon Corporation (Nasdaq: XON). Some of the statements made in this presentation are forward-looking stat ...
Intrexon Corp (XON) CEO RJ Kirk on Precigen Inc Business and Pipeline Update Conference Call (Transcript)
2019-11-12 22:42
Intrexon Corp (XON) Precigen Inc Business and Pipeline Update Conference Call November 12, 2019 11:00 AM ET Company Participants Steven Harasym - VP, IR Dr. Helen Sabzevari - President, Precigen RJ Kirk - Chairman & CEO Conference Call Participants Jason Butler - JMP Securities Tyler Van Buren - Piper Jaffray Tejas Savant - JP Morgan Swayampakula Ramakanth - H.C. Wainwright Operator Good morning and welcome to the Precigen Business and Clinical Update Conference Call. All participants will be listen-only mo ...